EXS-21546
exscientia
['check,mate,056', 'nsclc', 'check,mate,017', 'sclc', 'ca,022,i', 'ca,022,1', 'renal,(-adrenal)', 'translational,medicine', 'ignite', 'check,mate,870', 'biomarker', 'summit', 'rcc,(-irccs),(-srcc),(-urcc)', 'selection,(-selectionlte),(-selection lte),(-selection-lte)', 'lung', 'check,mate,648', 'marker ']
#exscientia presents novel #immunooncology biomarker for #exs21546 at the #esmo i-o annual congress $exai 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.